78 related articles for article (PubMed ID: 10717180)
1. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
Hancock SL; Hoppe RT
Semin Radiat Oncol; 1996 Jul; 6(3):225-242. PubMed ID: 10717180
[TBL] [Abstract][Full Text] [Related]
2. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
Donaldson SS; Hancock SL; Hoppe RT
Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
[TBL] [Abstract][Full Text] [Related]
3. Long-term cause-specific mortality of patients treated for Hodgkin's disease.
Aleman BM; van den Belt-Dusebout AW; Klokman WJ; Van't Veer MB; Bartelink H; van Leeuwen FE
J Clin Oncol; 2003 Sep; 21(18):3431-9. PubMed ID: 12885835
[TBL] [Abstract][Full Text] [Related]
4. Late effects of Hodgkin's disease and its treatment.
Ng AK; Mauch PM
Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
[TBL] [Abstract][Full Text] [Related]
5. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease: complications of therapy and excess mortality.
Hoppe RT
Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
[TBL] [Abstract][Full Text] [Related]
7. [The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Balwierz W; Moryl-Bujakowska A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Sopyło B; Stańczak E; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Odój T; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Kołtan S; Krawczuk-Rybak M; Muszyńska-Rosłan K; Zuj G;
Przegl Lek; 2006; 63(1):25-8. PubMed ID: 16892895
[TBL] [Abstract][Full Text] [Related]
8. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
9. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
10. Analysis of competing risks of causes of death and their variation over different time periods in Hodgkin's disease.
Provencio M; Millán I; España P; Sánchez AC; Sánchez JJ; Cantos B; Vargas JA; Bellas C; García V; Sabin P; Bonilla F
Clin Cancer Res; 2008 Aug; 14(16):5300-5. PubMed ID: 18698050
[TBL] [Abstract][Full Text] [Related]
11. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
Bar Ad V; Paltiel O; Glatstein E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275
[TBL] [Abstract][Full Text] [Related]
16. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
[TBL] [Abstract][Full Text] [Related]
17. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P
Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748
[TBL] [Abstract][Full Text] [Related]
18. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
Hemminki K; Lenner P; Sundquist J; Bermejo JL
J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
[TBL] [Abstract][Full Text] [Related]
19. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
van der Maazen RW; Raemaekers JM
Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
